Prothena | PRTA - سرمایه عادی

قیمت سهام
10.34
تغییر روزانه
-0.16 -1.52%
ماهیانه
7.93%
سالیانه
1.17%
Q2 پیش بینی
10.19




سرمایه عادی تغییر دادن تاریخ
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Agios Pharmaceuticals USD 58.45M 169K 2025-12
Akebia Therapeutics USD 265.42M 199K 2025-12
ALKERMES USD 165.61M 503K 2025-12
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
Amgen USD 539M 1000K 2025-12
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 192.3M 201K 2025-12
Exelixis USD 268.1M 2.03M 2025-09
Immunic USD 8K 4K 2024-06
Incyte USD 198.46M 2.33M 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
MacroGenics USD 63.32M 60K 2025-12
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Neurocrine Biosciences USD 100.1M 400K 2025-12
Prothena USD 53.83M 3K 2025-12
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Vertex Pharmaceuticals USD 254M 0 2025-12
Xoma USD 87K 1000 2024-06